WeChat Mini Program
Old Version Features

A Cost-Utility Analysis of Adding SGLT2 Inhibitors for the Management of Type 2 Diabetes with Chronic Kidney Disease in Thailand

Natthakan Chitpim,Pattara Leelahavarong,Juthamas Prawjaeng, Sakditat Ittiphisit,Varalak Srinonprasert,Tanawan Kongmalai

SCIENTIFIC REPORTS（2025）

Cited 0|Views1
Key words
Type 2 diabetes,Chronic kidney disease,Cost-effectiveness,Cost-utility analysis,Economic evaluation,SGLT-2 inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined